Trial Profile
Evaluation and Treatment of Reflux Disease in Patients With Head and Neck Cancer Undergoing Radiation Therapy That Causes Significant Mucositis in the Reflux Field and Xerostomia.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 06 Sep 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 09 May 2012 Planned initiation date changed from 1 Apr 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 09 May 2012 Planned end date changed from 1 Apr 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.